Suomi - suomi - Fimea (Suomen lääkevirasto)

ceva santÉ animale - porcine parvovirus, inactivated, erysipelothrix rhusiopathiae bacterium, serotype 2, inactivated - injektioneste, suspensio - inaktivoitu sian parvovirus -rokote + inaktivoitu erysipelothrix rokote

Suomi - suomi - Fimea (Suomen lääkevirasto)

salfarm danmark a/s - erysipelothrix rhusiopathiae -bakteeri, serotyyppi 1, inaktiv.,sian parvovirus, inaktivoitu,erysipelothrix rhusiopathiae -bakteeri, serotyyppi 2, inaktiv. - injektioneste, emulsio - inaktivoitu sian parvovirus -rokote + inaktivoitu erysipelothrix rokote

Suomi - suomi - Fimea (Suomen lääkevirasto)

zoetis animal health aps - erysipelothrix rhusiopathiae, inactivated, strain b-7, serotype 2, porcine parvovirus, inactivated, strain s-80 - injektioneste, emulsio - inaktivoitu sian parvovirus -rokote + inaktivoitu erysipelothrix rokote

Suomi - suomi - Fimea (Suomen lääkevirasto)

laboratorios syva s.a. - erysipelothrix rhusiopathiae, inactivated, strain se-9, serotype 2, porcine parvovirus inactivated, strain pvp-7 - injektioneste, emulsio - inaktivoitu sian parvovirus -rokote + inaktivoitu erysipelothrix rokote

Suomi - suomi - Fimea (Suomen lääkevirasto)

intervet international b.v. - sian parvovirus inaktivoitu, kanta 014 - injektioneste, suspensio - sian parvovirus -rokote

Euroopan unioni - suomi - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologisia valmisteita varten felidae, - kissat - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Euroopan unioni - suomi - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologisia valmisteita varten felidae, - kissat - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Suomi - suomi - Fimea (Suomen lääkevirasto)

lohmann animal health gmbh - chicken anaemia virus, live - kuiva-aine, kylmäkuivattu, juomaveteen sekoitettavaksi - sinisiipitauti -rokote

Euroopan unioni - suomi - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - immunologisia valmisteita varten felidae, - kissat - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. immuniteettia on osoitettu viikon kuluttua rhinotracheiitin, kalikiviruksen, chlamydophila felisin ja panleukopenia -komponenttien ensisijaisesta rokotuskurssista. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Suomi - suomi - Fimea (Suomen lääkevirasto)

sanofi pasteur europe - hepatiitti a-virus (gbm), kokovirus, inaktivoitu,salmonella typhi (ty2) bakteerit, vi polysakkaridi - liuos ja suspensio injektionestettä varten, suspensio, esitäytetty ruisku - lavantauti - hepatiitti a -rokote